These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice. McGrath KC; Li X; Twigg SM; Heather AK PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125 [TBL] [Abstract][Full Text] [Related]
9. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor. Lee HY; Bae YS Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454 [TBL] [Abstract][Full Text] [Related]
10. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. Navab M; Ruchala P; Waring AJ; Lehrer RI; Hama S; Hough G; Palgunachari MN; Anantharamaiah GM; Fogelman AM J Lipid Res; 2009 Aug; 50(8):1538-47. PubMed ID: 19225094 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice. Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190 [TBL] [Abstract][Full Text] [Related]
12. Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit Sun Z; Huang W; Zheng Y; Liu P; Yang W; Guo Z; Kong D; Lv Q; Zhou X; Du Z; Jiang H; Jiang Y Front Immunol; 2021; 12():786602. PubMed ID: 34899755 [No Abstract] [Full Text] [Related]
13. L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils. Sharifov OF; Xu X; Gaggar A; Tabengwa EM; White CR; Palgunachari MN; Anantharamaiah GM; Gupta H Inflammation; 2014 Oct; 37(5):1401-12. PubMed ID: 24647607 [TBL] [Abstract][Full Text] [Related]
14. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling. Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578 [TBL] [Abstract][Full Text] [Related]
15. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria. Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862 [TBL] [Abstract][Full Text] [Related]
17. Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors. Peng X; Xu E; Liang W; Pei X; Chen D; Zheng D; Zhang Y; Zheng C; Wang P; She S; Zhang Y; Ma J; Mo X; Zhang Y; Ma D; Wang Y J Cell Sci; 2016 May; 129(9):1831-42. PubMed ID: 26966188 [TBL] [Abstract][Full Text] [Related]
18. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. Partida-Sánchez S; Iribarren P; Moreno-García ME; Gao JL; Murphy PM; Oppenheimer N; Wang JM; Lund FE J Immunol; 2004 Feb; 172(3):1896-906. PubMed ID: 14734775 [TBL] [Abstract][Full Text] [Related]
19. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels. Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028 [TBL] [Abstract][Full Text] [Related]
20. Potential clinical utility of high-density lipoprotein-mimetic peptides. Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]